ANNOUNCING NEW TARGETED CLINICAL TRIAL FOR EWING SARCOMA

~/media/Images/Banners/Homepage/EwingsRotator2016.ashxANNOUNCING NEW TARGETED CLINICAL TRIAL FOR EWING SARCOMA--> falsehttp://marycrowley.org/en/Media/News%20and%20Press%20Releases/~/media/8D05AA84FEBD472BBE630F224A577D79.ashxSee Detailed Press Release
~/media/Images/Homepage/Michael_Dumas_Rotator.ashx?20161021T1353335168PATIENT STORIESThe staff at Mary Crowley work hard; they're very in tune with the needs of their patients.--> false/sitecore/content/Home/Testimonials/Additional Testimonials/Michael DumasRead His Story
— Michael DumasPatient
~/media/Images/Banners/Homepage/LectureSeriesRotator2016.ashxPHYSICIAN LECTURE SERIES Learn how to navigate patients through the genomic maze --> false/Home/Our Research/Lecture Series.aspxRead More
~/media/Images/Homepage/FDARotator.ashxFDA APPROVES "Cabometyx" cancer drug approved by FDA- Feb 2016. Previously tested in clinical trials at Mary Crowley. --> false
~/media/Images/Banners/Homepage/DennisSchwanke2016.ashxPATIENT STORIESHis cancer was diagnosed on Friday 13th but his luck changed after receiving a new immune therapy. --> false/Home/Testimonials/Additional Testimonials/Dennis Schwanke.aspxRead His Story

Where Compassion Meets Science

Our mission is to expand treatment options for all cancer patients through investigational vaccine, gene and cellular therapies.

 


Follow Us

Find Us

Clinic:
7777 Forest Lane, Building C, Suite 707
Dallas, TX 75230
972-566-3000
Administrative Offices:
12222 Merit Drive
Suite 1500
Dallas, TX 75251
(214) 658-1999